Table 2.
Cohort EEG Findings by Outcome. P values reported from Fisher’s exact test.
| Total (N = 22) |
Alive (N = 16) |
Expired in hospital (N = 6) |
P | |
|---|---|---|---|---|
| EEG indication | ||||
| Altered mental status (AMS) | 17 (77.3%) | 12 (75.0%) | 5 (83.3%) | >0.999 |
| Seizure-like event (SLE) | 5 (22.7%) | 4 (25.0%) | 1 (16.7%) | >0.999 |
| Patients on anesthesia during EEG | 14 (63.6%) | 9 (56.2%) | 5 (83.3%) | 0.351 |
| Presence of clinical seizure | 2 (9.1%) | 1 (6.2%) | 1 (16.7%) | 0.481 |
| Epileptic EEG | 5 (22.7%) | 3 (18.8%) | 2 (33.3%) | 0.585 |
| Presence of GPDs | 7 (31.8%) | 6 (37.5%) | 1 (16.7%) | 0.616 |
| Presence of PDR | 11 (50.0%) | 9 (56.2%) | 2 (33.3%) | 0.635 |
| Presence of GRDA | 11 (50.0%) | 10 (62.5%) | 1 (16.7%) | 0.149 |
| Patient started on ASMs | 6 (27.3%) | 4 (25.0%) | 2 (33.3%) | >0.999 |
| ASMs continued after discharge | 2 (9.1%) | 1 (6.2%) | 1 (16.7%) | 0.766 |
AMS = Altered Mental Status, SLE = Seizure-like event, GPD = Generalized Periodic Discharges, PDR = Posterior Dominant Rhythm, GRDA = Generalized Rhythmic Delta Activity, ASMs = Anti-seizure medications.